ºÝºÝߣ

xeraya capital life sciences covid-19 coronavirus venture capital esg private equity ai xerayacapital healthcare biotechnology crispr vaccines allecra gram negative bacteria pharmaceutical circular economy gene therapy fda medical technology biomedical antibiotics genome mrna vaccine mab monoclonal antibodies talen gene editing green economy renewable resources glycoproteomics drug approvals vaccine production human microbiome clinical trial stem cells emergency use authorization mrna microbiome astrazeneca adult leukemia oxford vaccine chromatography plasma separation preparative electrophoresis plasma derivatives chrono therapeutics smoking cessation blood plasma tobacco entrepreneurship drug resistant bacteria pandemic serial entrepreneurs elon musk eric lefkofsky 3d printing nanotechnology artificial intelligence sustainable financing impact investing liquidia bacteria machine learning blood disease public policies who severe acute respiratory syndrome sars bone marrow disease mers hospital acquired pneumonia urinary tract infection hospital acquired infections medicine symbiosis microbiota health qualcomm ventures ge ventures google ventures cvc corporate venture capital lanzatech recycle carbon diagnosis capture carbon bio fuels jet fuel bio ethanol 2019 trends industry report genetic engineering zinc finger cas9 medical devices prime biologics dna rna bacteria defense crispr cas bacteriophages #xerayacapital primebiologics agriculture industry investment medical factsnfigures imago bio oncomyx acute myeloid leukemia aml socially responsible investment responsible investment governance social environment bone marrow transplant market study cell therapy novel drugs drug therapy cder nonalcoholic fatty liver disease nafld nash data analytics data sharing cord blood progenitor cells green investment msci sustainable investment sustainable development ri sri zfn cancer immunotherapy genome engineering genome editing augmented reality virtual reality telehealth telemedicine digital healthcare digital health renewable energy specialty chemicals renewable chemicals high blood pressure pah pulmonary hypertension pulmonary arterial hypertension equity financing raise capital financing rounds funding rounds carbon offset carbon credit climate change #carbon exchange cannabis sativa cbd thc cannabis legal status pain control cannabis pharma medical marijuana cannabis gmo nitrogen fixation malnutrition world hunger food security companion diagnostics adenoma tumor detection cancer analytes non-invasive biopsy liquid biopsy transplantation sclerosis diabetes ind animal testing new drugs drug testing immunogenicity vaccine manufacturing immune response b-cell t-cell recombinant vector vaccine dna plasmid vaccine herd immunity vaccine platforms rna drugs immunomodulatory agents cytokine release syndrome cytokine storm elisa dna test rna test immunology assay antibody assay isothermal amplification rt-pcr diagnostics socio economic impact mortality rate healthcare system innovation regenerative medicine financing series healthcare technology deep learning genomics analysis rtificial intelligence sovereign wealth fund swf rna technologies vaccination antiviral drugs treatment therapeutics immunization covid19 gene control gene expression epigenetic therapies epigenetic pathways epigenetics biontech pfizer moderna inclusive vaccines iva cepi post marketing drug discovery nda